参考文献/References:
[1] Bloom A.Remission in diabetes[J].Br Med J, 1959,2(5154):731-734.DOI:10.1136/bmj.2.5154.731.
[2] 杨雪,陈国芳,刘超.逆转2型糖尿病的现状与展望[J].中华糖尿病杂志,2021,13(7):666-672.DOI:10.3760/cma.j.cn115791-20210305-00127.
[3] Kelly J,Karlsen M,Steinke G.Type 2 diabetes remission and lifestyle medicine:a position statement from the American College of Lifestyle Medicine[J].Am J Lifestyle Med,2020,14(4):406-419.DOI:10.1177/1559827620930962.
[4] Rosenfeld RM,Kelly JH,Agarwal M,et al.Dietary interventions to treat type 2 diabetes in adults with a goal of remission:an expert consensus statement from the American College of Lifestyle Medicine[J].Am J Lifestyle Med,2022,16(3):342-362.DOI:10.1177/15598276221087624.
[5] Buse JB,Caprio S,Cefalu WT,et al.How do we define cure of diabetes?[J]. Diabetes Care,2009,32(11):2133-2135.DOI:10.2337/dc09-9036.
[6] Riddle MC,Cefalu WT,Evans PH,et al.Consensus report:definition and interpretation of remission in type 2 diabetes[J].Diabetes Care,2021,44(10):2438-2444.DOI:10.2337/dci21-0034.
[7] 中华医学会糖尿病学分会肥胖与糖尿病学组.2型糖尿病代谢手术术后管理中国专家共识[J].中华糖尿病杂志,2018,10(3):161-167.DOI:10.3760/cma.j.issn.1674-5809.2018.03.001.
[8] Nagi D,Hambling C,Taylor R.Remission of type 2 diabetes:a position statement from the Association of British Clinical Diabetologists(ABCD)and the Primary Care Diabetes Society(PCDS)[J].Br J Diabetes,2019,19(1):73-76.DOI:10.15277/bjd.2019.221.
[9] Dagenais GR,Leong DP,Rangarajan S,et al.Variations in common diseases,hospital admissions,and deaths in middle-aged adults in 21 countries from five continents(PURE):a prospective cohort study[J].Lancet,2020,395(10226):785-794.DOI:10.1016/S0140-6736(19)32007-0.
[10] Shibib L,Al-Qaisi M,Ahmed A,et al.Reversal and remission of T2DM -an update for practitioners[J].Vasc Health Risk Manag,2022,18:417-443.DOI:10.2147/VHRM.S345810.
[11] Ko JH,Kim TN.Type 2 diabetes remission with significant weight loss:definition and evidence-based interventions[J].J Obes Metab Syndr,2022,31(2):123-133.DOI:10.7570/jomes22001.
[12] Banerjee ES,Schroeder R,Harrison TD.Metabolic surgery for adult obesity:common questions and answers[J].Am Fam Physician,2022,105(6):593-601.
[13] Park S,Choi SB.Induction of long-term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insulin infusion therapy[J].Diabetes Metab Res Rev,2003,19(2):124-130.DOI:10.1002/dmrr.343.
[14] Li Y,Xu W,Liao Z,et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function[J].Diabetes Care,2004,27(11):2597-2602.DOI:10.2337/diacare.27.11.2597.
[15] Taylor R,Al-Mrabeh A,Sattar N.Understanding the mechanisms of reversal of type 2 diabetes[J].Lancet Diabetes Endocrinol,2019,7(9):726-736.DOI:10.1016/S2213-8587(19)30076-2.
[16] Weng J.Short-term intensive insulin therapy could be the preferred option for new onset type 2 diabetes mellitus patients with HbA1c>9[J].J Diabetes,2017,9(10):890-893.DOI:10.1111/1753-0407.12581.
[17] Russel SM,Valle V,Spagni G,et al.Physiologic mechanisms of type II diabetes mellitus remission following bariatric surgery:a meta-analysis and clinical implications[J].J Gastrointest Surg,2020,24(3):728-741.DOI:10.1007/s11605-019-04508-2.
[18] Taylor R.Type 2 diabetes and remission:practical management guided by pathophysiology[J].J Intern Med,2021,289(6):754-770.DOI:10.1111/joim.13214.
[19] Hallberg SJ,Gershuni VM,Hazbun TL,et al.Reversing type 2 diabetes:a narrative review of the evidence[J].Nutrients,2019,11(4):766.DOI:10.3390/nu11040766.
[20] Ge L,Sadeghirad B,Ball GDC,et al.Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults:systematic review and network meta-analysis of randomised trials[J].BMJ,2020,369:m696.DOI:10.1136/bmj.m696.
相似文献/References:
[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(02):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(02):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(02):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(02):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(02):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(02):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(02):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
[11]陈莉明.“逆转”2型糖尿病,梦想照进现实[J].国际内分泌代谢杂志,2021,41(06):549.[doi:10.3760/cma.j.cn121383-20210927-09082]
Chen Liming..Remission type 2 diabetes mellitus, dream into reality[J].International Journal of Endocrinology and Metabolism,2021,41(02):549.[doi:10.3760/cma.j.cn121383-20210927-09082]